id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
inlawrev-3838	Papa, Jeff	Recent Developments in Indiana Evidence Law	2007	28	.pdf	application/pdf	12216	841	68	The court concluded that labels of commercially marketed drugs are properly admitted into evidence under the exception provided by Evidence Rule 803(17) to prove the composition of the drug. The court found that the Indiana Supreme Court had dealt with this issue regarding pharmaceuticals and found Rule 803(17) applicable in that because the tablets were in their original blister packs, it was sufficiently shown that the contents remained as the manufacturer packaged them.^'^ Forler contended that the Indiana Supreme Court had only applied this logic to highly-regulated pharmaceuticals, but the court stated that it saw no indication that our supreme court intended to foreclose any consideration ofother types of product labels as possibly falling under Evidence Rule 803(17).^^^ The court further noted that as both of these products were dangerous, where a product label warns consumers that it contains dangerous ingredients, the general public reasonably relies upon the accuracy of such wamings.	cache/inlawrev-3838.pdf	txt/inlawrev-3838.txt